Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × tisagenlecleucel × Clear all

NCT05075603 2025-10-23

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse

NCT03876028 2023-01-31

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase 1 Terminated

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03630159 2022-08-15

PORTIA

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse